154 related articles for article (PubMed ID: 14571156)
1. Reversal of antipsychotic-induced weight gain during quetiapine treatment.
Koponen H; Larmo I
Int Clin Psychopharmacol; 2003 Nov; 18(6):355-6. PubMed ID: 14571156
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.
Sacchetti E; Valsecchi P
Int Clin Psychopharmacol; 2003 Nov; 18(6):357-9. PubMed ID: 14571157
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
Mukundan A; Faulkner G; Cohn T; Remington G
Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
[TBL] [Abstract][Full Text] [Related]
5. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
[TBL] [Abstract][Full Text] [Related]
6. Weight gain and antipsychotics.
Mackin P
J Clin Psychiatry; 2005 Jul; 66(7):950-1; author reply 951. PubMed ID: 16013917
[No Abstract] [Full Text] [Related]
7. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
[No Abstract] [Full Text] [Related]
8. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine-induced myoclonus.
Velayudhan L; Kirchner V
Int Clin Psychopharmacol; 2005 Mar; 20(2):119-20. PubMed ID: 15729090
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine-induced weight gain and escitalopram.
Holzer L; Paiva G; Halfon O
Am J Psychiatry; 2005 Jan; 162(1):192-3. PubMed ID: 15625223
[No Abstract] [Full Text] [Related]
11. Myocarditis with quetiapine.
Roesch-Ely D; Van Einsiedel R; Kathöfer S; Schwaninger M; Weisbrod M
Am J Psychiatry; 2002 Sep; 159(9):1607-8. PubMed ID: 12202290
[No Abstract] [Full Text] [Related]
12. Delusions associated with quetiapine-related weight redistribution.
Wirshing DA; Boyd JA; Pierre JM; Saunders CS; Wirshing WC; Azizian K; Patel KR; Ashcraft JC; Darmandjian H; Feusner J
J Clin Psychiatry; 2002 Mar; 63(3):247-8. PubMed ID: 11926726
[No Abstract] [Full Text] [Related]
13. Weight loss and anorexia with quetiapine.
Khawaja IS; Azeem MW; Ebrahim A
Psychiatr Serv; 2005 Apr; 56(4):490. PubMed ID: 15812105
[No Abstract] [Full Text] [Related]
14. Second-generation antipsychotics cause weight gain in youths.
Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
[No Abstract] [Full Text] [Related]
15. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
16. Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol.
Atmaca M; Kuloglu M; Tezcan E; Gecici O; Ustundag B
Schizophr Res; 2003 Mar; 60(1):99-100. PubMed ID: 12505146
[No Abstract] [Full Text] [Related]
17. Diabetes mellitus during olanzapine and quetiapine treatment in Japan.
Cohen D
J Clin Psychiatry; 2005 Feb; 66(2):265-6; author reply 266-7. PubMed ID: 15705015
[No Abstract] [Full Text] [Related]
18. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
Lee SY; Park MH; Patkar AA; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
[TBL] [Abstract][Full Text] [Related]
19. A case of depersonalization-derealization syndrome during treatment with quetiapine.
Sarkar J; Jones N; Sullivan G
J Psychopharmacol; 2001 Sep; 15(3):209-11. PubMed ID: 11565631
[TBL] [Abstract][Full Text] [Related]
20. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
